Coral Laboratories Ltd.

View in App
389.95 +19.45 ▲5.3%

24 April 2024, 01:27:00 PM
Volume: 2,294

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.corallab.com
Market Cap 136.81 Cr.
Enterprise Value(EV) 79.38 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 25.49 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 15.02 Trailing Twelve Months Ending 2023-12
Industry PE 41.03 Trailing Twelve Months Ending 2023-12
Book Value / Share 487.60 Trailing Twelve Months Ending 2023-12
Price to Book Value 0.79 Calculated using Price: 382.95
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 0.36 Cr. 3,572,600 Shares
FaceValue 10
About Coral Laboratories Ltd.
Coral Laboratories was founded in 1994. The company is equipped with an ultra modern manufacturing unit in the state of Gujarat, Daman & today is a force to reckon with in the pharmaceutical industry; a fact which has been endorsed by the WHO GMP certification issued by the Food & Drugs Control Administration and ISO 9001-2000 Quality certification issued by American Quality Assessors.

Coral Laboratories Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Coral Laboratories Ltd. Performance

View details >>
1 Day
+5.25%
1 Week
+5.96%
1 Month
-1.63%
3 Month
-11.17%
6 Month
+40.40%
1 Year
+52.38%
2 Year
+40.27%
5 Year
+8.99%
10 Year
+323.86%

Coral Laboratories Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 17.46 19.18 18.17 11.04 8.88 6.22 10.74 6.18 4.15
Return on Capital Employed (%) 22.22 26.93 27.23 15.91 13.44 7.86 13.35 7.87 5.41
Return on Assets (%) 14.4 15.32 14.77 9.17 7.4 5.09 8.69 5.06 3.54

Coral Laboratories Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 59 70 109 116 114 116 137 156 155 172
Non Curr. Liab. 1 1 3 4 4 4 3 8 8 10
Curr. Liab. 12 18 19 20 18 25 28 26 12 17
Minority Int.
Equity & Liab. 72 89 131 140 136 144 168 190 174 199
Non Curr. Assets 22 25 58 68 52 48 39 59 51 61
Curr. Assets 50 65 74 72 84 96 129 131 124 138
Misc. Exp. not W/O
Total Assets 72 89 131 140 136 144 168 190 174 199

Coral Laboratories Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 59 77 95 92 91 71 97 76 78 66
Other Income 3 3 3 4 5 6 4 5 7 6
Total Income 62 80 99 97 96 76 100 80 85 72
Total Expenditure -47 -61 -72 -77 -79 -65 -81 -67 -74 -58
PBIDT 15 19 27 20 18 11 20 13 11 14
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation -3 -2 -2 -2 -2 -2 -2 -2 -2 -2
Taxation -3 -5 -8 -6 -5 -2 -4 -3 -2 -2
Exceptional Items 0 0 1 0 0
PAT 10 12 16 12 10 7 14 9 6 9
Adjusted EPS 27 35 46 35 29 20 38 25 18 25

Coral Laboratories Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 1 0 5 11 13 -1 -4 1 6 13
Cash Fr. Inv. 1 0 -3 -10 -13 3 -2 0 -6 -3
Cash Fr. Finan. 0 0 0 0 -3 -1 4 0 0 -6
Net Change 2 0 2 1 -2 1 -2 1 0 4
Cash & Cash Eqvt 7 7 9 4 2 3 1 2 3 6

Coral Laboratories Ltd. Shareholding Pattern

View details >>
9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 71.51 71.51 71.51 71.51 71.51 71.51 71.51 71.51 71.51
Public 28.49 28.49 28.49 28.49 28.49 28.49 28.49 28.49 28.49
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Coral Laboratories Ltd. Announcements

View details >>
Wed, 24 Apr 2024
Board Meeting Outcome for Appointment Of Mrs. Ruchi Pipara As Company Secretary And Compliance Officer
Appointment of Mrs. Ruchi Pipara as Company Secretary and Compliance Officer
Wed, 24 Apr 2024
Appointment of Company Secretary and Compliance Officer
Appointment of Company Secretary and Compliance Officer
Fri, 19 Apr 2024
Board Meeting Intimation for Appointment Of Company Secretary
CORAL LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/04/2024 inter alia to consider and approve Appointment of Company Secretary

Coral Laboratories Ltd. Technical Scans

View details >>
Tue, 23 Apr 2024
Higher Trade Quantity Higher Trade Quantity
Making Higher Highs for 2 Days Making Higher Highs for 2 Days
High Decrease in 1 Month High Decrease in 1 Month
High Decrease in 3 Months High Decrease in 3 Months
High Increase in 6 Months High Increase in 6 Months

Coral Laboratories Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 356,001.33 1,491.35 +0.4%
Cipla Ltd. 108,812.62 1,393.25 +3.5%
Divi's Laboratories Ltd. 100,075.02 3,805.00 +1.0%
Dr. Reddy's Laboratories Ltd. 99,325.26 5,975.00 +0.4%
Zydus Lifesciences Ltd. 96,553.18 936.85 -2.4%
Mankind Pharma Ltd. 95,896.87 2,391.65 -0.1%
Torrent Pharmaceuticals Ltd. 89,224.37 2,684.50 +1.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 39.97 1,491.35 +0.4%
Cipla Ltd. Consolidated 2023-12 29.34 1,393.25 +3.5%
Divi's Laboratories Ltd. Consolidated 2023-12 72.36 3,805.00 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.00 5,975.00 +0.4%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.47 936.85 -2.4%
Mankind Pharma Ltd. Consolidated 2023-12 55.52 2,391.65 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 59.72 2,684.50 +1.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.71 1,491.35 +0.4%
Cipla Ltd. Consolidated 2023-12 4.20 1,393.25 +3.5%
Divi's Laboratories Ltd. Consolidated 2023-12 7.68 3,805.00 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.70 5,975.00 +0.4%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.12 936.85 -2.4%
Mankind Pharma Ltd. Consolidated 2023-12 10.79 2,391.65 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.48 2,684.50 +1.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,491.35 +0.4%
Cipla Ltd. Consolidated 2023-03 0.02 1,393.25 +3.5%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,805.00 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,975.00 +0.4%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 936.85 -2.4%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,391.65 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,684.50 +1.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,491.35 +0.4%
Cipla Ltd. Consolidated 2023-03 12.85 1,393.25 +3.5%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,805.00 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,975.00 +0.4%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 936.85 -2.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,391.65 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,684.50 +1.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,491.35 +0.4%
Cipla Ltd. Consolidated 2023-03 12.85 1,393.25 +3.5%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,805.00 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,975.00 +0.4%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 936.85 -2.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,391.65 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,684.50 +1.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,491.35 +0.4%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,393.25 +3.5%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,805.00 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,975.00 +0.4%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 936.85 -2.4%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,391.65 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,684.50 +1.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,491.35 +0.4%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,393.25 +3.5%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,805.00 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,975.00 +0.4%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 936.85 -2.4%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,391.65 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,684.50 +1.8%

Coral Laboratories Ltd. FAQ's

What is Coral Laboratories share price?
Can I buy Coral Laboratories shares now?
What is the Market Cap of Coral Laboratories?
What are the key metrics to analyse Coral Laboratories?
What is the 52 Week High and Low of Coral Laboratories?
What is the trend of Coral Laboratories share price?